Catalyst Pharmaceuticals (CPRX) Cash from Operations (2010 - 2026)
Catalyst Pharmaceuticals posted quarterly Cash from Operations of 59587000.0 for Q1 2026, down 0.76% year-on-year from 60043000.0 in Q1 2025, and up 32.74% on a QoQ basis from 44891000.0 in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 17 years of Cash from Operations data on file, last reported at 59587000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 0.76% year-over-year to 59587000.0; the trailing twelve-month figure through Mar 2026 stood at 208214000.0 (down 22.29% YoY), and the FY2025 full-year result was 208670000.0, down 12.98% from the prior year.
- Cash from Operations for Q1 2026 stood at 59587000.0, up from 44891000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 72871000.0 in Q3 2024 and bottomed at 8478000.0 in Q1 2022.
- The 5-year median for Cash from Operations is 44891000.0 (2025), against an average of 45159529.41.
- The widest annual swing landed in 2024, when Cash from Operations soared 164.5%; it then plunged 55.49% in 2025.
- A 5-year view of Cash from Operations shows it stood at 40077000.0 in 2022, then soared by 38.85% to 55648000.0 in 2023, then gained by 27.37% to 70877000.0 in 2024, then plunged by 36.66% to 44891000.0 in 2025, then surged by 32.74% to 59587000.0 in 2026.
- The last three Cash from Operations figures came in at 59587000.0 (Q1 2026), 44891000.0 (Q4 2025), and 32438000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 59.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.59 Mn |
| Mar 31, 2026 | 59.59 Mn |
| Dec 31, 2025 | 44.89 Mn |
| Dec 31, 2025 | 44.89 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Sep 30, 2025 | 32.44 Mn |
| Jun 30, 2025 | 71.30 Mn |
| Jun 30, 2025 | 71.30 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Mar 31, 2025 | 60.04 Mn |
| Dec 31, 2024 | 70.88 Mn |
| Dec 31, 2024 | 70.88 Mn |
| Sep 30, 2024 | 72.87 Mn |
| Sep 30, 2024 | 72.87 Mn |
| Jun 30, 2024 | 64.14 Mn |
| Jun 30, 2024 | 64.14 Mn |
| Mar 31, 2024 | 31.93 Mn |
| Mar 31, 2024 | 31.93 Mn |
| Dec 31, 2023 | 55.65 Mn |
| Dec 31, 2023 | 55.65 Mn |
| Sep 30, 2023 | 45.13 Mn |
| Sep 30, 2023 | 45.13 Mn |
| Jun 30, 2023 | 30.75 Mn |
| Jun 30, 2023 | 30.75 Mn |
| Mar 31, 2023 | 12.07 Mn |
| Mar 31, 2023 | 12.07 Mn |
| Dec 31, 2022 | 40.08 Mn |
| Dec 31, 2022 | 40.08 Mn |
| Sep 30, 2022 | 41.30 Mn |
| Sep 30, 2022 | 41.30 Mn |
| Jun 30, 2022 | 26.19 Mn |
| Jun 30, 2022 | 26.19 Mn |
| Mar 31, 2022 | 8.48 Mn |
| Mar 31, 2022 | 8.48 Mn |
| Dec 31, 2021 | 19.18 Mn |
| Dec 31, 2021 | 19.18 Mn |
| Sep 30, 2021 | 21.71 Mn |
| Sep 30, 2021 | 21.71 Mn |
| Jun 30, 2021 | 15.68 Mn |
| Jun 30, 2021 | 15.68 Mn |
| Mar 31, 2021 | 3.81 Mn |
| Mar 31, 2021 | 3.81 Mn |
| Dec 31, 2020 | 13.11 Mn |
| Dec 31, 2020 | 13.11 Mn |
| Sep 30, 2020 | 11.45 Mn |
| Sep 30, 2020 | 11.45 Mn |
| Jun 30, 2020 | 13.27 Mn |
| Jun 30, 2020 | 13.27 Mn |
| Mar 31, 2020 | 7.21 Mn |
| Mar 31, 2020 | 7.21 Mn |
| Dec 31, 2019 | 12.29 Mn |
| Dec 31, 2019 | 12.29 Mn |
| Sep 30, 2019 | 16.26 Mn |
| Sep 30, 2019 | 16.26 Mn |
| Jun 30, 2019 | 14.07 Mn |
| Jun 30, 2019 | 14.07 Mn |
| Mar 31, 2019 | -8.02 Mn |
| Mar 31, 2019 | -8.02 Mn |
| Dec 31, 2018 | -8.35 Mn |
| Dec 31, 2018 | -8.35 Mn |
| Sep 30, 2018 | -6.95 Mn |
| Sep 30, 2018 | -6.95 Mn |
| Jun 30, 2018 | -4.76 Mn |
| Jun 30, 2018 | -4.76 Mn |
| Mar 31, 2018 | -6.08 Mn |
| Mar 31, 2018 | -6.08 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Sep 30, 2017 | -2.63 Mn |
| Sep 30, 2017 | -2.63 Mn |
| Jun 30, 2017 | -3.20 Mn |
| Jun 30, 2017 | -3.20 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Mar 31, 2017 | -3.88 Mn |
| Dec 31, 2016 | -4.41 Mn |
| Dec 31, 2016 | -4.41 Mn |
| Sep 30, 2016 | -3.28 Mn |
| Sep 30, 2016 | -3.28 Mn |
| Jun 30, 2016 | -4.34 Mn |
| Jun 30, 2016 | -4.34 Mn |
| Mar 31, 2016 | -5.93 Mn |
| Mar 31, 2016 | -5.93 Mn |
| Dec 31, 2015 | -4.63 Mn |
| Dec 31, 2015 | -4.63 Mn |
| Sep 30, 2015 | -5.34 Mn |
| Sep 30, 2015 | -5.34 Mn |
| Jun 30, 2015 | -4.25 Mn |
| Jun 30, 2015 | -4.25 Mn |
| Mar 31, 2015 | -3.79 Mn |
| Mar 31, 2015 | -3.79 Mn |
| Dec 31, 2014 | -3.98 Mn |
| Dec 31, 2014 | -3.98 Mn |
| Sep 30, 2014 | -3.55 Mn |
| Sep 30, 2014 | -3.55 Mn |
| Jun 30, 2014 | -2.98 Mn |
| Jun 30, 2014 | -2.98 Mn |
| Mar 31, 2014 | -2.43 Mn |
| Mar 31, 2014 | -2.43 Mn |
| Dec 31, 2013 | -4.13 Mn |
| Dec 31, 2013 | -4.13 Mn |
| Sep 30, 2013 | -1.68 Mn |
| Sep 30, 2013 | -1.68 Mn |
| Jun 30, 2013 | -1.81 Mn |
| Jun 30, 2013 | -1.81 Mn |
| Mar 31, 2013 | -2.25 Mn |
| Mar 31, 2013 | -2.25 Mn |
| Dec 31, 2012 | -1.59 Mn |
| Dec 31, 2012 | -1.59 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Sep 30, 2012 | -1.10 Mn |
| Jun 30, 2012 | -1.14 Mn |
| Jun 30, 2012 | -1.14 Mn |
| Mar 31, 2012 | -1.30 Mn |
| Mar 31, 2012 | -1.30 Mn |
| Dec 31, 2011 | -1.44 Mn |
| Dec 31, 2011 | -1.44 Mn |
| Sep 30, 2011 | -1.25 Mn |
| Sep 30, 2011 | -1.25 Mn |
| Jun 30, 2011 | -1.46 Mn |
| Jun 30, 2011 | -1.46 Mn |
| Mar 31, 2011 | -831,119.00 |
| Mar 31, 2011 | -831,119.00 |
| Dec 31, 2010 | -769,152.00 |
| Dec 31, 2010 | -769,152.00 |
| Sep 30, 2010 | -817,344.00 |
| Sep 30, 2010 | -817,344.00 |